TW200302830A - Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate - Google Patents

Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate Download PDF

Info

Publication number
TW200302830A
TW200302830A TW092100611A TW92100611A TW200302830A TW 200302830 A TW200302830 A TW 200302830A TW 092100611 A TW092100611 A TW 092100611A TW 92100611 A TW92100611 A TW 92100611A TW 200302830 A TW200302830 A TW 200302830A
Authority
TW
Taiwan
Prior art keywords
ray diffraction
compound
hydrate
hemi
fumarate
Prior art date
Application number
TW092100611A
Other languages
English (en)
Chinese (zh)
Inventor
Akira Hiraide
Kenji Kamada
Kaichiro Koyama
Hitoshi Shimizu
Gary H Ward
Vandana K Cheruvallath
Stephan Parent
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of TW200302830A publication Critical patent/TW200302830A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
TW092100611A 2002-01-11 2003-01-13 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate TW200302830A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002004680 2002-01-11
JP2002076708 2002-03-19

Publications (1)

Publication Number Publication Date
TW200302830A true TW200302830A (en) 2003-08-16

Family

ID=27736409

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092100611A TW200302830A (en) 2002-01-11 2003-01-13 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate

Country Status (7)

Country Link
US (1) US20050176938A1 (enExample)
EP (1) EP1463743A1 (enExample)
JP (1) JP2005519934A (enExample)
AU (1) AU2003202137A1 (enExample)
CA (1) CA2472603A1 (enExample)
TW (1) TW200302830A (enExample)
WO (1) WO2003068793A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10339882A1 (de) * 2003-06-26 2005-01-13 Continental Teves Ag & Co. Ohg Hydraulikaggregat für schlupfgeregelte Bremsanlagen
US7141769B2 (en) * 2005-04-01 2006-11-28 Cem Corporation Spectroscopy-based real-time control for microwave-assisted chemistry

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY113693A (en) * 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
JP3258914B2 (ja) * 1995-08-03 2002-02-18 中外製薬株式会社 エリスロマイシン誘導体の製造方法
ZA966601B (en) * 1995-08-03 1997-02-19 Chugai Pharmaceutical Co Ltd Process for producing erythromycin derivatives.
US5945405A (en) * 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
SK142000A3 (en) * 1997-07-08 2000-06-12 Biochemie Sa Erythromycin a oxime solvates

Also Published As

Publication number Publication date
US20050176938A1 (en) 2005-08-11
JP2005519934A (ja) 2005-07-07
AU2003202137A1 (en) 2003-09-04
EP1463743A1 (en) 2004-10-06
CA2472603A1 (en) 2003-08-21
WO2003068793A1 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
EP2970123B1 (en) Salt of omecamtiv mecarbil and process for preparing salt
US10301287B2 (en) Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate
KR20160118204A (ko) 2-하이드록시-6-((2-(1-이소프로필-1h-피라졸-5-일)피리딘-3-일)메톡시)벤즈알데하이드의 유리 염기의 결정성 다형체
KR20150028971A (ko) 항바이러스성 화합물의 고체 형태
CN103360391B (zh) 阿哌沙班新晶型及其制备方法
JP2013540810A (ja) 1−{(2S)−2−アミノ−4−[2,4−ビス(トリフルオロメチル)−5,8−ジヒドロピリド[3,4−d]ピリミジン−7(6H)−イル]−4−オキソブチル}−5,5−ジフルオロピペリジン−2−オン酒石酸塩の水和物
TW201829423A (zh) Janus激酶抑制劑之結晶型
JP2016183193A (ja) フィダキソマイシンの固体状形態およびその調製方法
EP2468762A1 (en) Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
JP2009527484A (ja) (+)−r−ジロートンの新規結晶形態および医薬組成物
TWI868593B (zh) 新生黴素(novobiocin)類似物及脯胺酸之共晶型及其用途
TW202333676A (zh) 吡唑並〔3,4-d〕嘧啶化合物之固體形式
JP2019512542A (ja) 結晶塩形態
TW200302830A (en) Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate
EP4461727A1 (en) Crystal form of 7-azaspiro[4,5]decane-6,10-dione compound and preparation method therefor
WO2013170243A1 (en) Form 5 polymorph of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine
JP6357100B2 (ja) 6−(ピペリジン−4−イルオキシ)−2h−イソキノリン−1−オン塩酸塩の結晶性溶媒和物
US20090233967A1 (en) Crystalline forms of mc4r agonist and process for synthesis
WO2026032320A1 (zh) 异噁唑啉类药物中间体的制备方法
EP3098220A1 (en) Process for the preparation of a nadph oxidase inhibitor and its polymorphs and uses thereof
EP4608832A1 (en) 2-(4-(2-(7, 8-dimethyl-[1,2,4]triazolo[1,5-a] pyridin-6-yl)-3-isopropyl-1h-indol-5-yl)piperidin-1-yl)acetamide salt and crystalline forms thereof
WO2023222103A1 (zh) 一种三嗪二酮类衍生物的晶型及制备方法
WO2020001460A1 (zh) 氮杂双环基取代的三唑类衍生物的可药用盐、晶型及制备方法
HK1219484B (zh) 心肌肌球蛋白激动剂的盐和制备盐的方法
CA2614048A1 (en) Improved crystalline form of the compound a-348441